No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
MeSH terms
-
Adult
-
Anaplastic Lymphoma Kinase
-
Antineoplastic Agents / therapeutic use*
-
Female
-
Humans
-
Lymphoma, Large-Cell, Anaplastic / drug therapy*
-
Lymphoma, Large-Cell, Anaplastic / genetics
-
Male
-
Middle Aged
-
Pyrimidines / therapeutic use*
-
Receptor Protein-Tyrosine Kinases / genetics
-
Sulfones / therapeutic use*
-
Treatment Outcome
-
Young Adult
Substances
-
Antineoplastic Agents
-
Pyrimidines
-
Sulfones
-
ALK protein, human
-
Anaplastic Lymphoma Kinase
-
Receptor Protein-Tyrosine Kinases
-
ceritinib
Associated data
-
ClinicalTrials.gov/NCT01283516